Innovent Biologics
Facts
as of Nov 22, 2026Innovent Biologics is a Chinese biopharmaceutical company headquartered in Suzhou, Jiangsu, that discovers, develops, manufactures and sells medicines for cancer, metabolic, autoimmune and other serious diseases. Founded in 2011 and listed in Hong Kong, it markets the PD-1 antibody sintilimab under the Tyvyt brand and co-develops the GLP-1 and glucagon receptor agonist mazdutide with Eli Lilly, with research and commercial teams across Suzhou, Shanghai, Hangzhou and Beijing. It hires medicinal chemistry and DMPK leaders, CMC development researchers, medical science liaisons, clinical research associates, regional marketing managers and information security engineers.
It is hiring: 290 open roles, 0 of them posted in the last 30 days.
- Headquarters
- Suzhou, China
- Founded
- 2011
- Employees
- 1001-5000estimated range
- Open roles
- 290 in 28 citiesAlion job postings
- Official records
- Wikidata Q106004358LEI 25490058ONL9SCIE1R22
- Website
- innoventbio.com
As of Nov 22, 2026, Alion lists 290 open roles at Innovent Biologics. Innovent Biologics is headquartered in Suzhou, China. It was founded in 2011.
People
All open roles →290 open roles, 0 of them posted in the last 30 days.
Products
Products →Innovent Biologics has 1 clinical trials on record, 0 under way.
Risk
Full record →Innovent Biologics: 198 research papers in five years.
Peers
Compare →Ranked #9 by open roles among its 11 closest peers.
| # | Company | HQ | Open roles | Size | |
|---|---|---|---|---|---|
| 1 | Amgen | Thousand Oaks, United States | 1,182 | 5000+ | |
| 2 | AstraZeneca | Cambridge, United Kingdom | 966 | 5000+ | |
| 3 | Roche | Basel, Switzerland | 809 | 5000+ | |
| 4 | Merck & Co. | Rahway, United States | 719 | 5000+ | |
| 9 | Innovent Biologics | Suzhou, China | 290 | 1001-5000 |
